C-reactive protein-to-albumin ratio and six-month mortality in incident hemodialysis patients

References

• Erratum: kidney Disease: improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney int suppl. 2017;7:1–59. Kidney Int Suppl. 2017;7(3):e1.
   Web of Science ®Google Scholar
• Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–2047.
   PubMed Web of Science ®Google Scholar
• Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–272.
   PubMed Web of Science ®Google Scholar
• Anderson S, Halter JB, Hazzard WR, et al. Prediction, progression, and outcomes of chronic kidney disease in older adults. Published Online. 2009;20(6):1199–1209.
   Google Scholar
• Bello AK, Levin A, Lunney M, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross-sectional survey. BMJ. 2019;367:38.
   Google Scholar
• Benjamin O, Lappin SL. End-stage renal disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021; Published online February 4, 2021. Accessed October 11, 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499861/
   Google Scholar
• Schena FP. Epidemiology of end-stage renal disease: international comparisons of renal replacement therapy. Kidney Int. 2000;57(74):S39–S45.
   Google Scholar
• Hiyamuta H, Yamada S, Taniguchi M, Nakano T, Tsuruya K. Causes of death in patients undergoing maintenance hemodialysis in Japan: 10-year outcomes of the Q-cohort study. Clin Exp Nephrol. 2021;25(10):1121–1130.
   PubMed Web of Science ®Google Scholar
• Broers NJH, Cuijpers ACM, Sande F V D, et al. The first year on haemodialysis: a critical transition. Clin Kidney J. 2015;8(3):271–277.
   PubMedGoogle Scholar
• Bargman JM, Golper TA. The importance of residual renal function for patients on dialysis. Nephrol Dial Transplant. 2005;20(4):671–673.
   PubMed Web of Science ®Google Scholar
• Lukowsky LR, Kheifets L, Arah OA, et al. Patterns and predictors of early mortality in incident hemodialysis patients: new insights. Am J Nephrol. 2012;35(6):548–558.
   PubMed Web of Science ®Google Scholar
• Hazara AM, Bhandari S. Early mortality rates After commencement of maintenance hemodialysis: a systematic review and meta-analysis. Ther Apher Dial. 2020;24(3):275–284.
   PubMed Web of Science ®Google Scholar
• Msaad R, Essadik R, Mohtadi K, et al. Predictors of mortality in hemodialysis patients. Pan Afr Med J. 2019;33:61.
   PubMed Web of Science ®Google Scholar
• Nr S, S J. Hypoalbuminemia in hemodialyzed end stage renal disease patients: risk factors and relationships–a 2 year single center study. BMC Nephrology. 2013;14(1):242.
   Google Scholar
• Ikizler TA, Cuppari L. The 2020 updated KDOQI clinical practice guidelines for nutrition in chronic kidney disease. Blood Purif. 2021;50:667–671.
   PubMed Web of Science ®Google Scholar
• Yu J, Park JY, Ha S, et al. C-reactive protein/albumin ratio and acute kidney injury after radical cystectomy among elderly patients: a propensity score-matched analysis. Dis Markers. 2020;2020:8818445.
   PubMed Web of Science ®Google Scholar
• Peng W, Zhang C, Wang Z, et al. Prediction of all-cause mortality with hypoalbuminemia in patients with heart failure: a meta-analysis. Biomarkers. 2019;24(7):631–637.
   PubMed Web of Science ®Google Scholar
• Furukawa M, Kinoshita K, Yamaguchi J, et al. Sepsis patients with the complication of hypoglycemia and hypoalbuminemia are an early and easy identification of high mortality risk. Intern Emerg Med. 2019;14(4):539–548.
   PubMed Web of Science ®Google Scholar
• Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15(5):458–482.
   PubMed Web of Science ®Google Scholar
• Park JE, Chung KS, Song JH, et al. The C-reactive protein/albumin ratio as a predictor of mortality in critically ill patients. J Clin Med. 2018;7(10):333.
   Web of Science ®Google Scholar
• Ranzani OT, Zampieri FG, Forte DN, et al. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLOS One. 2013;8(3):e59321.
   PubMed Web of Science ®Google Scholar
• Murat SN, Kurtul A, Yarlioglues M. Impact of serum albumin levels on contrast-induced acute kidney injury in patients with acute coronary syndromes treated with percutaneous coronary intervention. Angiology. 2015;66(8):732–737.
   PubMed Web of Science ®Google Scholar
• Wu M, Guo J, Guo L, et al. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. Tumour Biol. 2016;37(9):12525–12533.
   PubMedGoogle Scholar
• Kaplan M, Ates I, Akpina MY, et al. Predictive value of C-reactive protein/albumin ratio in acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2017;16(4):424–430.
   PubMed Web of Science ®Google Scholar
• Oh TK, Song IA, Lee JH. Clinical usefulness of C-reactive protein to albumin ratio in predicting 30-day mortality in critically ill patients: a retrospective analysis. Sci Rep. 2018 8:1. 2018;8(1):1–6.
   PubMedGoogle Scholar
• Ju S, Ma S. High C-reactive protein to albumin ratio and the short-term survival prognosis within 30 days in terminal cancer patients receiving palliative care in a hospital setting: a retrospective analysis. Medicine. 2020;99(9):e19350.
   Web of Science ®Google Scholar
• Póvoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 2002;28(3):235–243.
   PubMed Web of Science ®Google Scholar
• E D de V, Jm M, Jj R, et al. Association of a low serum albumin with infection and increased mortality in critically ill patients. Intensive Care Med. 1980;7(1):19–22.
   PubMed Web of Science ®Google Scholar
• Liu S, Qiu P, Luo L, et al. Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis. Ren Fail. 2020;42(1):600–606.
   PubMed Web of Science ®Google Scholar
• Chan K, Moe SM, Saran R, et al. The cardiovascular-dialysis nexus: the transition to dialysis is a treacherous time for the heart. Eur Heart J. 2021;42(13):1244–1253.
   PubMed Web of Science ®Google Scholar
• Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome– The heart of the matter. Nephrology Dialysis Transplantation. 2002;17(SUPPL. 11):28–31.
   PubMed Web of Science ®Google Scholar
• Lodebo BT, Shah A, Kopple JD. Is it important to prevent and treat protein-energy wasting in chronic kidney disease and chronic dialysis patients? J Ren Nutr. 2018;28(6):369–379.
   PubMed Web of Science ®Google Scholar
• Rao P, Reddy GC, Kanagasabapathy AS. Malnutrition-inflammation-atherosclerosis syndrome in chronic kidney disease. Indian J Clin Biochem. 2008;23(3):209–217.
   PubMedGoogle Scholar
• Kunizaki M, Tominaga T, Wakata K, et al. Clinical significance of the C-reactive protein-to-albumin ratio for the prognosis of patients with esophageal squamous cell carcinoma. Mol Clin Oncol. 2018;8(2):370–374.
   PubMed Web of Science ®Google Scholar
• Hwang JC, Jiang MY, Lu YH, et al. Precedent fluctuation of serum hs-CRP to albumin ratios and mortality risk of clinically stable hemodialysis patients. PLOS One. 2015;10(3):e0120266.
   PubMed Web of Science ®Google Scholar